发明名称 VIRAL DEFECTIVE VACCINE PRODUCED BY TRANSCOMPLEMENTING CELL LINE
摘要 <p>A mutant virus for use as a vaccine, wherein the genome of the virus is defective in respect of a gene essential for the pro- duction of infectious virus. In one aspect the mutant virus is capable of protecting a susceptible species immunized therewith against infection by the corresponding wild-type virus. In another aspect, t he mutant virus acts as a vector for an immunogenic protein derived from a pathogen and which is encoded by foreign DNA incorporated in the mutant virus. The mutant virus can be produced in a recombinant host cell which expresses a gene complementing the defect. The mutant virus is preferably infec- tious for the host to be protected, but the defective gene allows expression in the infected host of at least some of the viral genes, which can provoke a cell-mediated immune response.</p>
申请公布号 CA2091678(C) 申请公布日期 2003.04.22
申请号 CA19912091678 申请日期 1991.09.23
申请人 发明人 INGLIS, STEPHEN C.;BOURSNELL, MICHEAL E. G.;MINSON, ANTHONY C.
分类号 A61K39/00;A61K39/21;A61K39/245;A61P31/12;A61P31/22;C07K14/155;C12N7/00;C12N7/01;C12N15/09;C12N15/869;(IPC1-7):C12N7/01;C12N15/86;C12N7/04 主分类号 A61K39/00
代理机构 代理人
主权项
地址